Compile Data Set for Download or QSAR
maximum 50k data
Found 98 Enz. Inhib. hit(s) with all data for entry = 2335
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  17nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  17nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  17nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361992(US10221182, Compound E1-1.4 | US10221182, Compound...)
Affinity DataIC50:  18.5nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361992(US10221182, Compound E1-1.4 | US10221182, Compound...)
Affinity DataIC50:  18.5nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  21.2nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  21.2nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361999(US10221182, Compound E1-1.6 | US10221182, Compound...)
Affinity DataIC50:  21.2nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361992(US10221182, Compound E1-1.4 | US10221182, Compound...)
Affinity DataIC50:  21.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361992(US10221182, Compound E1-1.4 | US10221182, Compound...)
Affinity DataIC50:  21.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362001(US10221182, Compound E1-1.7 | US10221182, Compound...)
Affinity DataIC50:  22.4nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362001(US10221182, Compound E1-1.7 | US10221182, Compound...)
Affinity DataIC50:  22.4nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362001(US10221182, Compound E1-1.7 | US10221182, Compound...)
Affinity DataIC50:  22.4nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM280739(US10030026, Compound LX-1 | US10221182, Compound L...)
Affinity DataIC50:  24nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM280739(US10030026, Compound LX-1 | US10221182, Compound L...)
Affinity DataIC50:  24nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  25nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  25nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  25nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362003(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Affinity DataIC50:  27.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362003(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Affinity DataIC50:  27.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362003(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Affinity DataIC50:  27.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  31.7nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  31.7nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361989(US10221182, Compound E1-1.3 | US10221182, Compound...)
Affinity DataIC50:  31.7nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  32.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  32.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  32.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  37.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  37.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361982(US10221182, Compound E1-1.5 | US10221182, Compound...)
Affinity DataIC50:  37.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362001(US10221182, Compound E1-1.7 | US10221182, Compound...)
Affinity DataIC50:  38.1nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362001(US10221182, Compound E1-1.7 | US10221182, Compound...)
Affinity DataIC50:  38.1nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362003(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Affinity DataIC50:  61.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362003(US10221182, Compound E1-1.16 | US10221182, Compoun...)
Affinity DataIC50:  61.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361991(US10221182, Compound C-1.2)
Affinity DataIC50:  68.3nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361991(US10221182, Compound C-1.2)
Affinity DataIC50:  68.3nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361991(US10221182, Compound C-1.2)
Affinity DataIC50:  68.3nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362005(US10221182, Compound E1-1.11)
Affinity DataIC50:  68.4nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM362005(US10221182, Compound E1-1.11)
Affinity DataIC50:  68.4nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361995(US10221182, Compound C-1.34)
Affinity DataIC50:  72.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361995(US10221182, Compound C-1.34)
Affinity DataIC50:  72.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361994(US10221182, Compound C-1.15)
Affinity DataIC50:  78.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361994(US10221182, Compound C-1.15)
Affinity DataIC50:  78.9nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361984(US10221182, Compound C-1.1 | US10221182, Compound ...)
Affinity DataIC50:  83.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361984(US10221182, Compound C-1.1 | US10221182, Compound ...)
Affinity DataIC50:  83.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361984(US10221182, Compound C-1.1 | US10221182, Compound ...)
Affinity DataIC50:  98.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361984(US10221182, Compound C-1.1 | US10221182, Compound ...)
Affinity DataIC50:  98.8nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361986(US10221182, Compound C-1.33)
Affinity DataIC50:  103nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361986(US10221182, Compound C-1.33)
Affinity DataIC50:  103nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Rugen Holdings (Cayman)

US Patent
LigandPNGBDBM361985(US10221182, Compound C-2.5)
Affinity DataIC50:  105nMAssay Description:HEK293 cell lines stably expressing cloned human NR1/NR2B and NR1/NR2A, respectively, were established according to standard previously described met...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 98 total ) | Next | Last >>
Jump to: